One jab is not enough: two are needed for vaccination

Posted on

Just to fuel the Covid debate that is going on here, I offer this from the latest React Study from Imperial College London:

As they say:

In 971 individuals who received two doses of the Pfizer-BioNTech vaccine, the proportion testing positive was high across all age groups, at 91.1% (88.5, 97.1) overall. Following a single dose of Pfizer-BioNTech vaccine after 21 days or more, 84.1% (82.2, 85.9) of people under 60 years tested positive (unadjusted) with a decreasing trend with increasing age, but high responses to a single dose in those with confirmed or suspected prior COVID at 88.8% (85.9, 91.2) overall. (Table 4) The apparent higher positivity in people with prior COVID-19 was present in all age groups.

I suggest the evidence is abundant: two doses are needed, and the sooner the better.

A single dose does not appear to be achieving anything like the expected benefits, most especially for the vulnerable.

On this basis, government policy would appear to be placing wholly inappropriate faith in single-dose jabs that do not deliver vaccination for those who really need it.


Thanks for reading this post.
You can share this post on social media of your choice by clicking these icons:

You can subscribe to this blog's daily email here.

And if you would like to support this blog you can, here: